Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease

Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease

Objectives: To explore serum zinc-α2-glycoprotein (ZAG) changes in patients with or without premature coronary artery disease (PCAD) and its association with several cardiovascular risk factors.Methods: A total of 3,364 patients who were undergone coronary angiography in Peking Union Medical College...

Full description

Bibliographic Details
Main Authors: Meijuan Liu, Huijuan Zhu, Tianshu Zhai, Hui Pan, Linjie Wang, Hongbo Yang, Kemin Yan, Yong Zeng, Fengying Gong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Endocrinology
Subjects:
zinc-α2-glycoprotein (ZAG)
premature coronary artery disease (PCAD)
non-premature coronary artery disease (NPCAD)
body mass index (BMI)
diagnostic biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00197/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00197/full

Similar Items